Comment
doi: 10.1136/gutjnl-2019-320554.
Epub 2020 Feb 10.
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
Affiliations
- PMID: 32041745
- DOI: 10.1136/gutjnl-2019-320554
Item in Clipboard
Comment
Tenofovir versus entecavir in prevention of hepatocellular carcinoma and mortality in patients with chronic hepatitis B
Gut.
2020 Nov.
No abstract available
Keywords: chronic viral hepatitis; hepatocellular carcinoma.
Conflict of interest statement
Competing interests: None declared.
Comment on
-
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.Gut. 2020 Jul;69(7):1301-1308. doi: 10.1136/gutjnl-2019-318947. Epub 2019 Oct 31. Gut. 2020. PMID: 31672838 Free PMC article.
Similar articles
-
Tenofovir may be superior to entecavir for preventing hepatocellular carcinoma and mortality in individuals chronically infected with HBV: a meta-analysis.Gut. 2020 Oct;69(10):1900-1902. doi: 10.1136/gutjnl-2019-320326. Epub 2019 Dec 16. Gut. 2020. PMID: 31843789 No abstract available.
-
Entecavir versus tenofovir in patients with chronic hepatitis B: Enemies or partners in the prevention of hepatocellular carcinoma.Clin Mol Hepatol. 2021 Jul;27(3):402-412. doi: 10.3350/cmh.2021.0179. Epub 2021 Jun 23. Clin Mol Hepatol. 2021. PMID: 34157830 Free PMC article. Review.
-
Risk of Hepatocellular Carcinoma in Patients Treated With Entecavir vs Tenofovir for Chronic Hepatitis B: A Korean Nationwide Cohort Study.JAMA Oncol. 2019 Jan 1;5(1):30-36. doi: 10.1001/jamaoncol.2018.4070. JAMA Oncol. 2019. PMID: 30267080 Free PMC article.
-
Comparison of tenofovir and entecavir on the risk of hepatocellular carcinoma and mortality in treatment-naïve patients with chronic hepatitis B in Korea: a large-scale, propensity score analysis.Gut. 2020 Jul;69(7):1301-1308. doi: 10.1136/gutjnl-2019-318947. Epub 2019 Oct 31. Gut. 2020. PMID: 31672838 Free PMC article.
-
Comparison of tenofovir versus entecavir on reducing incidence of hepatocellular carcinoma in chronic hepatitis B patients: A systematic review and meta-analysis.J Gastroenterol Hepatol. 2020 Sep;35(9):1467-1476. doi: 10.1111/jgh.15036. Epub 2020 Mar 26. J Gastroenterol Hepatol. 2020. PMID: 32180249
Cited by
-
Tenofovir Hampers the Efficacy of Sorafenib in Prolonging Overall Survival in Hepatocellular Carcinoma.Biomedicines. 2021 Oct 26;9(11):1539. doi: 10.3390/biomedicines9111539. Biomedicines. 2021. PMID: 34829768 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
